Application Note: An Automated DELFIA ADCC Assay Method using a CD16.NK-92 Cell Line
8 March 2013

This application note discusses an automated, non-radioactive ADCC assay used in mAb immunotherapeutic development. Results demonstrate that when automated using Biotek instrumentation, the cell-based assay reduces active labor time. In addition, an increase in consistency and robustness are shown over time and across users.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions

Already a member?

Log in for full access to the article

Remember me